Duality Advisers LP Invests $1.77 Million in Prestige Consumer Healthcare Inc (NYSE:PBH)

Share on StockTwits

Duality Advisers LP bought a new stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 47,001 shares of the company’s stock, valued at approximately $1,765,000. Duality Advisers LP owned 0.09% of Prestige Consumer Healthcare at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of PBH. Jane Street Group LLC purchased a new position in Prestige Consumer Healthcare during the 4th quarter worth $483,000. New Mexico Educational Retirement Board raised its holdings in shares of Prestige Consumer Healthcare by 33.3% in the first quarter. New Mexico Educational Retirement Board now owns 12,000 shares of the company’s stock valued at $440,000 after acquiring an additional 3,000 shares in the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of Prestige Consumer Healthcare by 107.1% in the first quarter. BNP Paribas Arbitrage SA now owns 20,093 shares of the company’s stock valued at $737,000 after acquiring an additional 10,392 shares in the last quarter. Maverick Capital Ltd. purchased a new stake in Prestige Consumer Healthcare in the first quarter worth about $1,218,000. Finally, Legal & General Group Plc grew its holdings in Prestige Consumer Healthcare by 9.4% during the 1st quarter. Legal & General Group Plc now owns 68,151 shares of the company’s stock worth $2,500,000 after acquiring an additional 5,828 shares in the last quarter.

Shares of NYSE:PBH opened at $37.19 on Friday. The business’s 50-day moving average is $38.20 and its 200 day moving average is $39.22. The company has a debt-to-equity ratio of 1.50, a current ratio of 2.44 and a quick ratio of 1.67. Prestige Consumer Healthcare Inc has a 1 year low of $27.40 and a 1 year high of $46.12. The firm has a market capitalization of $1.87 billion, a P/E ratio of 13.38, a P/E/G ratio of 3.11 and a beta of 0.80.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.82 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.08. Prestige Consumer Healthcare had a return on equity of 13.33% and a net margin of 14.77%. The business had revenue of $251.20 million for the quarter, compared to analyst estimates of $239.65 million. The company’s revenue was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.72 earnings per share. On average, analysts expect that Prestige Consumer Healthcare Inc will post 2.99 EPS for the current year.

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 29,593 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $40.00, for a total value of $1,183,720.00. Following the completion of the transaction, the chief executive officer now owns 154,630 shares of the company’s stock, valued at $6,185,200. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.20% of the stock is currently owned by insiders.

Several equities research analysts have recently weighed in on the stock. ValuEngine cut shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 2nd. TD Securities upped their target price on Prestige Consumer Healthcare from $90.00 to $97.00 and gave the stock a “hold” rating in a report on Friday, July 24th. DA Davidson lifted their price target on Prestige Consumer Healthcare from $43.00 to $47.00 in a report on Wednesday, April 15th. Jefferies Financial Group downgraded Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 14th. Finally, TheStreet raised shares of Prestige Consumer Healthcare from a “c” rating to a “b-” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $65.43.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Further Reading: How liquidity affects the bid-ask spread

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 

Latest News

Different Types of Research Papers
Different Types of Research Papers
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing


 
© 2006-2020 BBNS.